MedPage Today on MSN
Monoclonal Antibody Prevented Relapse in Adult-Onset Nephrotic Syndrome
Primary nephrotic syndrome in adults, including minimal-change nephrotic syndrome, has an incidence of roughly 0.2 to 0.8 per ...
One monoclonal antibody, rituximab, can work wonders for the treatment of children with frequently relapsing nephrotic ...
THE "nephrotic syndrome" is one of the most striking phenomena of renal disease. The combination of gross edema, hypoproteinemia, hypercholesterolemia, lipidemia and heavy proteinuria, in the absence ...
The randomized, open-label INSHORE trial (ClinicalTrials.gov Identifier: NCT05627557) evaluated the safety and efficacy of obinutuzumab in children and young adults in clinical remission aged 2 to 25 ...
A groundbreaking study, presented today at the 61st ERA Congress, has uncovered a significant breakthrough in the diagnosis and monitoring of kidney diseases associated with nephrotic syndrome. Using ...
News-Medical.Net on MSN
Rituximab shows remarkable success in adults with relapsing nephrotic syndrome
One monoclonal antibody, rituximab, can work wonders for the treatment of children with frequently relapsing nephrotic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback